Literature DB >> 11114888

Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

R S Tibbetts1, D Cortez, K M Brumbaugh, R Scully, D Livingston, S J Elledge, R T Abraham.   

Abstract

The BRCA1 gene encodes a tumor suppressor that is mutated in 50% of familial breast cancers. The BRCA1 protein has been implicated in the DNA damage response, as DNA damage induces the phosphorylation of BRCA1 and causes its recruitment into nuclear foci that contain DNA repair proteins. The ataxia-telangiectasia-mutated (ATM) gene product controls overall BRCA1 phosphorylation in response to gamma-irradiation (IR). In this study, we show that BRCA1 phosphorylation is only partially ATM dependent in response to IR and ATM independent in response to treatment with UV light, or the DNA replication inhibitors hydroxyurea (HU) and aphidicolin (APH). We provide evidence that the kinase responsible for this phosphorylation is the ATM-related kinase, ATR. ATR phosphorylates BRCA1 on six Ser/Thr residues, including Ser 1423, in vitro. Increased expression of ATR enhanced the phosphorylation of BRCA1 on Ser 1423 following cellular exposure to HU or UV light, whereas doxycycline-induced expression of a kinase-inactive ATR mutant protein inhibited HU- or UV light-induced Ser 1423 phosphorylation in GM847 fibroblasts, and partially suppressed the phosphorylation of this site in response to IR. Thus, ATR, like ATM, controls BRCA1 phosphorylation in vivo. Although ATR isolated from DNA-damaged cells does not show enhanced kinase activity in vitro, we found that ATR responds to DNA damage and replication blocks by forming distinct nuclear foci at the sites of stalled replication forks. Furthermore, ATR nuclear foci overlap with the nuclear foci formed by BRCA1. The dramatic relocalization of ATR in response to DNA damage points to a possible mechanism for its ability to enhance the phosphorylation of substrates in response to DNA damage. Together, these results demonstrate that ATR and BRCA1 are components of the same genotoxic stress-responsive pathway, and that ATR directly phosphorylates BRCA1 in response to damaged DNA or stalled DNA replication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114888      PMCID: PMC317107          DOI: 10.1101/gad.851000

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  66 in total

1.  The FHA domain is a modular phosphopeptide recognition motif.

Authors:  D Durocher; J Henckel; A R Fersht; S P Jackson
Journal:  Mol Cell       Date:  1999-09       Impact factor: 17.970

2.  BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Authors:  H Ruffner; W Jiang; A G Craig; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Genetic analysis of BRCA1 function in a defined tumor cell line.

Authors:  R Scully; S Ganesan; K Vlasakova; J Chen; M Socolovsky; D M Livingston
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

4.  Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

Authors:  R Scully; J Chen; R L Ochs; K Keegan; M Hoekstra; J Feunteun; D M Livingston
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

5.  Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.

Authors:  R Khosravi; R Maya; T Gottlieb; M Oren; Y Shiloh; D Shkedy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

6.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

Authors:  Q Zhong; C F Chen; S Li; Y Chen; C C Wang; J Xiao; P L Chen; Z D Sharp; W H Lee
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

7.  The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53.

Authors:  N D Lakin; B C Hann; S P Jackson
Journal:  Oncogene       Date:  1999-07-08       Impact factor: 9.867

8.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

Authors:  D Cortez; Y Wang; J Qin; S J Elledge
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

9.  Recombinant ATM protein complements the cellular A-T phenotype.

Authors:  Y Ziv; A Bar-Shira; I Pecker; P Russell; T J Jorgensen; I Tsarfati; Y Shiloh
Journal:  Oncogene       Date:  1997-07-10       Impact factor: 9.867

10.  Substrate specificities and identification of putative substrates of ATM kinase family members.

Authors:  S T Kim; D S Lim; C E Canman; M B Kastan
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

View more
  148 in total

Review 1.  When repair meets chromatin. First in series on chromatin dynamics.

Authors:  Catherine M Green; Geneviève Almouzni
Journal:  EMBO Rep       Date:  2002-01       Impact factor: 8.807

2.  Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin.

Authors:  Lee Zou; David Cortez; Stephen J Elledge
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

3.  Two checkpoint complexes are independently recruited to sites of DNA damage in vivo.

Authors:  J A Melo; J Cohen; D P Toczyski
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

4.  ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation.

Authors:  P Nghiem; P K Park; Y Kim ; C Vaziri; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

5.  Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.

Authors:  B Xu; M B Kastan
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

6.  Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance.

Authors:  Eric J Brown; David Baltimore
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

7.  Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.

Authors:  L J Huber; T W Yang; C J Sarkisian; S R Master; C X Deng; L A Chodosh
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

8.  Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366.

Authors:  Gopal P Sapkota; Maria Deak; Agnieszka Kieloch; Nick Morrice; Aaron A Goodarzi; Carl Smythe; Yosef Shiloh; Susan P Lees-Miller; Dario R Alessi
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

9.  Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects.

Authors:  Lubomir Balabanski; Georgi Antov; Ivanka Dimova; Samuil Ivanov; Maria Nacheva; Ivan Gavrilov; Desislava Nesheva; Blaga Rukova; Savina Hadjidekova; Maxim Malinov; Draga Toncheva
Journal:  Mol Clin Oncol       Date:  2014-02-04

10.  Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.

Authors:  Erik S Zimmerman; Junjie Chen; Joshua L Andersen; Orly Ardon; Jason L Dehart; Jana Blackett; Shailesh K Choudhary; David Camerini; Paul Nghiem; Vicente Planelles
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.